When did Nurix Therapeutics, Inc. report Q4 2025 earnings?

Nurix Therapeutics, Inc. (NRIX) reported Q4 2025 earnings on January 28, 2026 before market open.

What were Nurix Therapeutics, Inc.'s Q4 2025 revenue and EPS?

Nurix Therapeutics, Inc. reported revenue of $13.6M and diluted EPS of $-0.82 for Q4 2025.

Did Nurix Therapeutics, Inc. beat estimates in Q4 2025?

Revenue beat the consensus estimate of $13.4M by $177.9K. EPS beat the consensus estimate of $-0.84 by $0.02.

How did Nurix Therapeutics, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 2.2% from $13.3M a year earlier and diluted EPS declined 9.3% from $-0.75.

Where can I find Nurix Therapeutics, Inc.'s Q4 2025 SEC filings?

You can read the 8-K earnings release (0001549595-26-000013) and the 10-K periodic report (0001549595-26-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.

Nurix Therapeutics, Inc. NRIX Q4 2025 Annual earnings

Reported January 28, 2026 · Before market open

Revenue$13.6MBeat by $177.9K Diluted EPS-$0.82Beat by $0.02

Revenue estimate$13.4M

EPS estimate-$0.84

Next report

Jul 9, 2026 (In 2 weeks)

Revenue estimate$15.9M

EPS estimate-$0.73

Versus estimates

Revenue

Q1 2026$6.3MMiss by $8.0M

Q4 2025$13.6MBeat by $177.9K

Q3 2025$7.9MMiss by $4.4M Q2 2025$44.1MBeat by $26.5M Q1 2025$18.5MBeat by $2.6M Q4 2024$13.3MMiss by $1.5M

Diluted EPS

Q1 2026-$0.79Miss by $0.03

Q4 2025-$0.82Beat by $0.02

Q3 2025-$1.03Miss by $0.19 Q2 2025-$0.52Beat by $0.19 Q1 2025-$0.67Beat by $0.05 Q4 2024-$0.75Miss by $0.08

Ask the moment Nurix Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Nurix Therapeutics, Inc. report Q4 2025 earnings?: Nurix Therapeutics, Inc. (NRIX) reported Q4 2025 earnings on January 28, 2026 before market open.
What were Nurix Therapeutics, Inc.'s Q4 2025 revenue and EPS?: Nurix Therapeutics, Inc. reported revenue of $13.6M and diluted EPS of $-0.82 for Q4 2025.
Did Nurix Therapeutics, Inc. beat estimates in Q4 2025?: Revenue beat the consensus estimate of $13.4M by $177.9K. EPS beat the consensus estimate of $-0.84 by $0.02.
How did Nurix Therapeutics, Inc.'s Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 2.2% from $13.3M a year earlier and diluted EPS declined 9.3% from $-0.75.
Where can I find Nurix Therapeutics, Inc.'s Q4 2025 SEC filings?: You can read the 8-K earnings release (0001549595-26-000013) and the 10-K periodic report (0001549595-26-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.